BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16320261)

  • 1. Evaluating technologies for classification and prediction in medicine.
    Pepe MS
    Stat Med; 2005 Dec; 24(24):3687-96. PubMed ID: 16320261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining predictors for classification using the area under the receiver operating characteristic curve.
    Pepe MS; Cai T; Longton G
    Biometrics; 2006 Mar; 62(1):221-9. PubMed ID: 16542249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Model comparison for automatic characterization and classification of average ERPs using visual oddball paradigm.
    Merzagora AC; Butti M; Polikar R; Izzetoglu M; Bunce S; Cerutti S; Bianchi AM; Onaral B
    Clin Neurophysiol; 2009 Feb; 120(2):264-74. PubMed ID: 19062338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics.
    Phan JH; Quo CF; Wang MD
    Prog Brain Res; 2006; 158():83-108. PubMed ID: 17027692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A hierarchical Naïve Bayes Model for handling sample heterogeneity in classification problems: an application to tissue microarrays.
    Demichelis F; Magni P; Piergiorgi P; Rubin MA; Bellazzi R
    BMC Bioinformatics; 2006 Nov; 7():514. PubMed ID: 17125514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penalized maximum likelihood estimation to directly adjust diagnostic and prognostic prediction models for overoptimism: a clinical example.
    Moons KG; Donders AR; Steyerberg EW; Harrell FE
    J Clin Epidemiol; 2004 Dec; 57(12):1262-70. PubMed ID: 15617952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An intelligent model for liver disease diagnosis.
    Lin RH
    Artif Intell Med; 2009 Sep; 47(1):53-62. PubMed ID: 19540738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivariable adjustments counteract spectrum and test review bias in accuracy studies.
    Bachmann LM; ter Riet G; Weber WE; Kessels AG
    J Clin Epidemiol; 2009 Apr; 62(4):357-361.e2. PubMed ID: 18620840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of biomarkers for risk stratification of cardiovascular events using genetic algorithm with recursive local floating search.
    Zhou X; Wang H; Wang J; Wang Y; Hoehn G; Azok J; Brennan ML; Hazen SL; Li K; Chang SF; Wong ST
    Proteomics; 2009 Apr; 9(8):2286-94. PubMed ID: 19337989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of matched case-control data with multiple ordered disease states: possible choices and comparisons.
    Mukherjee B; Liu I; Sinha S
    Stat Med; 2007 Jul; 26(17):3240-57. PubMed ID: 17206600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-SNP pharmacogenomic classifier is superior to single-SNP models for predicting drug outcome in complex diseases.
    Petrovski S; Szoeke CE; Sheffield LJ; D'souza W; Huggins RM; O'brien TJ
    Pharmacogenet Genomics; 2009 Feb; 19(2):147-52. PubMed ID: 19077679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy assessment of prediction in patient outcomes.
    Bartfay E; Bartfay WJ
    J Eval Clin Pract; 2008 Feb; 14(1):1-10. PubMed ID: 18211637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials: odds ratios and multiple regression models--why and how to assess them.
    Sobh M; Cleophas TJ; Hadj-Chaib A; Zwinderman AH
    Am J Ther; 2008; 15(1):44-52. PubMed ID: 18223353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The application of genomic and proteomic technologies in predictive, preventive and personalized medicine.
    Collins CD; Purohit S; Podolsky RH; Zhao HS; Schatz D; Eckenrode SE; Yang P; Hopkins D; Muir A; Hoffman M; McIndoe RA; Rewers M; She JX
    Vascul Pharmacol; 2006 Nov; 45(5):258-67. PubMed ID: 17030152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting carcinoid heart disease with the noisy-threshold classifier.
    van Gerven MA; Jurgelenaite R; Taal BG; Heskes T; Lucas PJ
    Artif Intell Med; 2007 May; 40(1):45-55. PubMed ID: 17098402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarker assay translation from discovery to clinical studies in cancer drug development: quantification of emerging protein biomarkers.
    Lee JW; Figeys D; Vasilescu J
    Adv Cancer Res; 2007; 96():269-98. PubMed ID: 17161683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appropriateness of some resampling-based inference procedures for assessing performance of prognostic classifiers derived from microarray data.
    Lusa L; McShane LM; Radmacher MD; Shih JH; Wright GW; Simon R
    Stat Med; 2007 Feb; 26(5):1102-13. PubMed ID: 16755534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.